Search - tctmd.com

Displaying 541 - 551 of 551

Sort: Relevancy | Date

Presentation TCT 2012

Cases 7 and 8: When and How to Use LV Support Devices in Acute MI

Presenter: Jose Henriques

October 26, 2012

Presentation TCT 2012

Should Left Ventricular Mechanical Support Be Used Routinely in Patients with LV Dysfunction and Cardiogenic Shock?

Presenter: Jeffrey Popma

October 25, 2012

Presentation TCT 2012

LV Apical Closure Devices

Presenter: Wilson Szeto

October 24, 2012

Presentation TCT 2012

Contemporary LVAD Therapy: Destination, Recovery, Bridge?

Presenter: Emma Birks

October 23, 2012

Presentation TCT 2012

Decreased LV Function and Aortic Stenosis: Assessment and Treatment Preferences

Presenter: Lars Svensson

October 22, 2012

Presentation TVT 2012

Transcatheter Treatment of LVAD-associated Aortic Regurgitation

Presenter: 136460|Atman Shah

June 02, 2012

Presentation

RIME: Mitral Valve Annuloplasty Plus CABG Improves Functional Capacity and Promotes Reverse Left Ventricular (LV) Remodeling

Presenter: 202166|KMJ Chan

March 01, 2012

Presentation

Renal Sympathetic Denervation Reduces LV Hypertrophy and Improves Cardiac Function in Patients with Resistant Hypertension

Presenter: M. Brandt

February 26, 2012

Presentation Cell Therapy 2012

Trial 1: SCIPIO: Autologous Cardiac-Derived Stem Cells for LV Dysfunction

Presenter: Roberto Bolli

January 25, 2012

Presentation Cell Therapy 2012

Alster Stem Cell: NOGA-XP Guided Intramyocardial Autologous Cell Therapy Improves LV Function After Large Acute Myocardial Infarct

Presenter: Martin Bergmann

January 25, 2012

$Improvements in LV Function and Afterload with TandemHeart for the Treatment of Refractory Cardiogenic Shock$

Presentation TCT 2012

Improvements in LV Function and Afterload with TandemHeart for the Treatment of Refractory Cardiogenic Shock

Presenter: Michael Tempelhof, Nirat Beohar, Chris Malaisrie, Patrick McCarthy, Charles Davidson

January 03, 2012

Advertisement

Cases 7 and 8: When and How to Use LV Support Devices in Acute MI

Should Left Ventricular Mechanical Support Be Used Routinely in Patients with LV Dysfunction and Cardiogenic Shock?

LV Apical Closure Devices

Contemporary LVAD Therapy: Destination, Recovery, Bridge?

Decreased LV Function and Aortic Stenosis: Assessment and Treatment Preferences

Transcatheter Treatment of LVAD-associated Aortic Regurgitation

RIME: Mitral Valve Annuloplasty Plus CABG Improves Functional Capacity and Promotes Reverse Left Ventricular (LV) Remodeling

Renal Sympathetic Denervation Reduces LV Hypertrophy and Improves Cardiac Function in Patients with Resistant Hypertension

Trial 1: SCIPIO: Autologous Cardiac-Derived Stem Cells for LV Dysfunction

Alster Stem Cell: NOGA-XP Guided Intramyocardial Autologous Cell Therapy Improves LV Function After Large Acute Myocardial Infarct

Improvements in LV Function and Afterload with TandemHeart for the Treatment of Refractory Cardiogenic Shock

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content